Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like OvaScience Pinks Slips Nearly 50% of Workforce January 3, 2018 Rumors Surface M&A-Desperate Gilead is Nearing a Deal to Buy Incyte March 12, 2017 Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017
Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017
